Doctors Note Logo

Published on: 10/26/2026

How Often the RSV Vaccine Is Needed, and Who Is Eligible

RSV vaccination is currently a one-time dose for most adults rather than an annual shot, and revaccination is not recommended at this time. Eligibility generally includes adults 75 and older, adults 50 to 74 with risk factors such as chronic heart or lung disease, diabetes, obesity, weakened immune systems, or residence in a nursing home, and pregnant people between 32 and 36 weeks of pregnancy during RSV season, while infants may instead receive a protective antibody injection. Timing, product choice, and spacing from other vaccines can change what is right for you, so there are several important details to consider below.

If you are coughing, wheezing, feverish, or short of breath and unsure whether RSV, flu, COVID, or something else is behind it, guessing can delay care that works best in the first few days of illness. A free, instant, online symptom check can help you sort through your symptoms, understand likely causes, and decide whether to rest at home, call your doctor, or seek urgent care now.

Last reviewed for medical accuracy: 10/22/2026

answer background

Concerned about your symptoms?

Explanation

How Often Is RSV Vaccine Required, and Who Is Eligible

Respiratory Syncytial Virus (RSV) can cause serious lung and airway infections in babies, older adults and people with certain health conditions. Thanks to recent advances, safe and effective RSV vaccines and antibody products are now available. Understanding how often you need protection and who should get it can help you plan ahead.

How Often Is RSV Vaccine Required?

Current recommendations focus on timing protection around RSV “season” (usually fall through spring), when infections rise. Here’s how often different groups should receive RSV prevention:

  • Adults 60 years and older

    • One dose of RSV vaccine each RSV season.
    • Optimal timing: before local RSV activity ramps up (often late summer or early fall).
    • If you miss the usual window, getting vaccinated later is better than not at all.
  • Pregnant people (to protect newborns)

    • A single dose during each pregnancy, ideally between 32 and 36 weeks gestation.
    • Even if you’ve had RSV vaccine in a previous pregnancy, you should receive it again for each new pregnancy.
  • Infants and young children at high risk

    • A one-time dose of RSV monoclonal antibody (nirsevimab) before the first RSV season.
    • In some high-risk infants (e.g., born extremely premature or with certain heart/lung conditions), a second dose may be considered if their first dose was given very early before the season starts.
    • No routine RSV vaccination for otherwise healthy infants or toddlers; focus is on those at highest risk.
  • Adults 50–59 years and 18–49 years with underlying conditions

    • Not currently recommended for routine use in healthy adults under 60, but if you have chronic lung disease, heart disease, severe immunocompromise or other risk factors, talk to your doctor about whether RSV vaccine might be appropriate off-label.

Why a Once-a-Season Dose?

  • RSV infections peak seasonally, similar to flu.
  • Protection wanes gradually over months, so a yearly dose before the season provides optimal coverage.
  • Annual dosing simplifies scheduling—just like the annual influenza shot—so you don’t miss the window of peak RSV activity.

Who Is Eligible for RSV Vaccination?

Eligibility differs by age group and health status. Below is a summary based on the latest U.S. Centers for Disease Control and Prevention (CDC) and Advisory Committee on Immunization Practices (ACIP) guidance.

  1. Adults Aged 60 and Older

    • All adults 60+ are recommended to receive one RSV vaccine dose each season.
    • Two different vaccines are available; your healthcare provider can help choose the best option.
  2. Pregnant People (During Each Pregnancy)

    • One dose between 32–36 weeks of pregnancy to boost antibodies passed to the baby.
    • Protects infants during their first few months, when they’re most vulnerable.
  3. Infants and Young Children at High Risk

    • Nirsevimab monoclonal antibody is approved for infants born at any gestational age.
    • A single dose is given just before RSV season starts.
    • Eligible infants include those born prematurely (<35 weeks gestation), with chronic lung disease, congenital heart disease, neuromuscular disorders, or severe immunocompromise.
  4. Adults 18–59 with High-Risk Conditions

    • No universal recommendation, but if you have severe heart or lung disease, immune compromise, or other factors, discuss RSV vaccination with your doctor.
    • They may consider it to reduce severe illness risk.

Why Certain Groups Are Prioritized

  • Older adults often have weaker immune responses and more chronic health conditions, increasing the chance of severe RSV illness.
  • Infants, especially those born early or with medical issues, lack fully developed lungs and immune systems.
  • Pregnant people receive a maternal vaccine not just for themselves but to protect infants too young to be vaccinated.
  • Immunocompromised individuals (any age) may not clear the virus well and can develop serious complications.

Benefits of RSV Vaccination

  • Reduces the chance of hospitalization and severe lung disease.
  • Lowers the need for intensive medical care, such as breathing support.
  • Protects against long-term respiratory issues that sometimes follow severe RSV infection.
  • Contributes to community immunity, reducing virus spread to vulnerable people.

Practical Tips for Getting Your RSV Vaccine

  • Plan ahead: Talk to your healthcare provider in late summer or early fall to schedule your RSV vaccine.
  • Combine visits: If you’re also due for flu or COVID-19 vaccines, ask if you can get them at the same appointment.
  • Keep records: Note the date and which vaccine you received—especially important for pregnant people who need one dose per pregnancy.
  • Stay informed: RSV season timing can vary by region; check local health department updates.

Recognizing RSV Symptoms

Even with vaccination, some people may still get mild RSV. Common symptoms include:

  • Runny nose, congestion
  • Coughing
  • Fever (not always present)
  • Decreased appetite
  • Wheezing or rapid breathing (more common in infants and older adults)

If you or a loved one develops worrisome symptoms—trouble breathing, bluish lips, high fever, refusal to drink fluids—seek medical care right away.

Before You Go…

Not sure if your symptoms are RSV or something else? Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help guide you on next steps and whether you should see a healthcare professional.

Speak to a Doctor

The information here offers general guidance. Always discuss your individual health situation with a qualified healthcare provider. If you experience severe or life-threatening symptoms, seek medical help immediately.

(References)

  • * Karron RA, Wright PF, Crowe JE Jr, Clements-Mann ML, Thompson J, Makhene M, Casey R, Murphy BR. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J Infect Dis. 1997 Dec;176(6):1428-36. doi: 10.1086/514138. PMID: 9395351.

  • * Schuster JE, O'Leary S, Kimberlin DW. Update From the Advisory Committee on Immunization Practices. J Pediatric Infect Dis Soc. 2016 Dec;5(4):349-355. doi: 10.1093/jpids/piw057. Epub 2016 Oct 7. PMID: 27856770.

  • * Gaviria-Agudelo C, Yonts AB, Kimberlin DW, O'Leary ST, Paulsen GC. February 2023 Updates of the Advisory Committee on Immunization Practices. J Pediatric Infect Dis Soc. 2023 May 31;12(5):257-261. doi: 10.1093/jpids/piad026. PMID: 37094832.

  • * Melgar M, Britton A, Roper LE, Talbot HK, Long SS, Kotton CN, Havers FP. Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. Am J Transplant. 2023 Oct;23(10):1631-1640. doi: 10.1016/j.ajt.2023.09.003. PMID: 37778868.

  • * Abbasi HQ, Oduoye MO. Revitalizing hope for older adults: The use of the novel Arexvy for immunization against respiratory syncytial virus. Health Sci Rep. 2023 Oct;6(10):e1648. doi: 10.1002/hsr2.1648. Epub 2023 Oct 25. PMID: 37916140; PMCID: PMC10617982.

  • * Anastassopoulou C, Medić S, Ferous S, Boufidou F, Tsakris A. Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines. Vaccines (Basel). 2025 Jan 21;13(2). doi: 10.3390/vaccines13020097. Epub 2025 Jan 21. PMID: 40006644; PMCID: PMC11860200.

  • * Urquiaga M, Winthrop KL, Curtis JR. Vaccination Update and Specific Concerns for RA. Curr Rheumatol Rep. 2025 Sep 17;27(1):37. doi: 10.1007/s11926-025-01197-6. Epub 2025 Sep 17. PMID: 40960573; PMCID: PMC12443919.

  • * O'Hagan S, Williams TC, Marlow R, Drysdale SB, Cunningham S, Groves HE, Mpamhanga CD, Lyttle MD, Hunt S, Liu X, Waterfield T, Roland D, Iskander D, Woolfall K, PERUKI & BronchStart Collaboration. Maternal perspectives on the RSV vaccine (Abrysvo): a thematic analysis of survey findings from the first season of implementation in England and Scotland. Arch Dis Child. 2026 Jun 22;111(7):618-624. doi: 10.1136/archdischild-2025-329427. Epub 2026 Jun 22. PMID: 41741000; PMCID: PMC13311973.

  • * Kao CM, Bahakel H, Heald-Sargent TA, Minniear TD, Statler VA, Thomas SJ, Weakley KE, Cao Q, Ardura MI, Danziger-Isakov L, Foca M, Herold BC. Influenza, COVID-19, and RSV Vaccinations for Immunocompromised Children and Household Contacts. Pediatrics. 2026 Aug 1;158(2). doi: 10.1542/peds.2026-075971. PMID: 42486492.

  • * Senerth E, Sheikholeslamian SM, Babatunde I, Falk J, Watson MA, Saini H, Tangri N, Lipson RA, Sivakumaran K, Wharton M, Ulrich AK, Moat LE, Stoddart CJ, Walensky RP, Basta NE, Morgan RL. RSV Immunization Effectiveness and Safety for the 2026-2027 Respiratory Season. JAMA. 2026 Sep 2. doi: 10.1001/jama.2026.17871. Epub 2026 Sep 2. PMID: 42684247.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.